Association of cardiac events with coronary artery disease detected by 64-slice or greater coronary CT angiography: A systematic review and meta-analysis

作者：Habib Phillip J; Green Jacinta; Butterfield Ryan C; Kuntz Gretchen M; Murthy Raguveer; Kraemer Dale F; Percy Robert F; Miller Alan B; Strom Joel A^*

来源：International Journal of Cardiology, 2013, 169(2): 112-120.

DOI：10.1016/j.ijcard.2013.08.096

• Cardiovascular events
• Coronary artery disease
• Coronary CT angiography
• Meta-analysis

Background: The value of = 64-slice coronary CT angiography (CCTA) to determine odds of cardiac death or nonfatal myocardial infarction (MI) needs further clarification.
Methods: We performed a systematic review and meta-analysis using publications reporting events/severity of coronary artery disease (CAD) in patients with suspected CAD undergoing CCTA. Patients were divided into: no CAD, non-obstructive CAD (maximal stenosis b50%), and obstructive CAD (= 50% stenosis). Odds ratios with 95% confidence intervalswere calculated using a fixed or randomeffectsmodel. Heterogeneitywas assessed using the I2 index.
Results: We included thirty-two studies comprising 41,960 patients with 363 all-cause deaths (15.0%), 114 cardiac deaths (4.7%), 342 MI (14.2%), 69 unstable angina (2.8%), and 1527 late revascularizations (63.2%) over 1.96 (SD 0.77) years of follow-up. Cardiac death or MI occurred in 0.04% without, 1.29% with non-obstructive, and 6.53% with obstructive CAD. OR for cardiac death or MI was: 14.92 (95% CI, 6.78 to 32.85) for obstructive CAD, 6.41 (95% CI, 2.44 to 16.84) for non-obstructive CAD versus no CAD, and 3.19 (95% CI, 2.29 to 4.45) for non-obstructive versus obstructive CAD and 6.56 (95% CI, 3.07 to 14.02) for no versus any CAD. Similar trends were noted for all-cause mortality and composite major adverse cardiovascular events.
Conclusions: Increasing CAD severity detected by CCTA is associatedwith cardiac death orMI, all-causemortality, and composite major adverse cardiovascular events. Absence of CAD is associated with very low odds of major adverse events, but non-obstructive disease significantly increases odds of cardiac adverse events in this follow-up period.

• 出版日期2013-10-30